Incidensen af alvorlige infektioner var 0, 03 pr. patientår hos Trudexa- behandlede patienter og 0, 03 pr. patientår hos placebo - og aktiv kontrolbehandlede patienter.
tho The incidence of serious infections was 0.03 per patient year in Trudexa treated patients and 0.03 per patient year in placebo and active control− treated patients.